Historic Win for Foster Youth and Families: A New Medicaid Benefit Becomes Reality
Los Angeles, CA, June 10, 2025 (GLOBE NEWSWIRE) — Special Needs Network is proud to announce a major policy victory that will change lives across California. Thanks to our leadership and collaboration with state partners, a brand-new Medicaid benefit – the Fee-for-Service Behavioral Health Treatment (FFS BHT) benefit – will launch statewide on July 1, 2025. The new provider enrollment portal is open so providers can be ready to serve patients day one. SNN will be ready.
'This is a monumental step forward for California's foster youth and families,' said Areva Martin, President of Special Needs Network. 'Creating a brand-new Medicaid benefit in record time shows what's possible when community advocates, policymakers, and government agencies work together. We are proud that Special Needs Network's leadership helped drive this historic change — and we remain committed to ensuring that every child gets the care and support they deserve.'
This breakthrough ensures that foster youth and all other children needing behavioral health therapy will finally have direct access to services under Medi-Cal, with more providers available and fewer barriers to care.,. Access will no longer be determined by whether a child has a managed care plan or FFS Medi-Cal or whether they are served by a regional center or not.
Creating this new benefit involved: Securing federal approval for a new Medicaid State Plan.
Building a statewide provider enrollment system.
Establishing new billing codes and payment systems.
Ensuring access for smaller community organizations and paraprofessionals.
Eliminating referral barriers for families, physicians, and courts.
SNN played a critical role at every step, providing technical expertise, real-world feedback, and advocacy that state officials have called 'invaluable.'
Although the benefit launches July 1, work continues to refine the system and fully support providers, youth, and families. SNN will remain deeply involved in training, communications, system improvements, and monitoring to ensure a smooth rollout and lasting success. Priority processing is available through June 30. See the FAQs for providers here
'This win represents one of the fastest and most significant Medicaid benefit developments in California history — and it was fueled by SNN's dedication to children, families, and equitable access to care,' said Kristin Jacobson, a policy expert and long-time advocate who participated in this effort on behalf of SNN.
To submit a PAVE application, agencies need to visit the PAVE (Provider Application and Validation for Enrollment) system portal: https://pave.dhcs.ca.gov/
_________________________________________________________________________
Special Needs Network, Inc. (SNN) is a nonprofit grassroots organization responding to the crisis of autism and other developmental disabilities in underserved communities. We recognize the intersectionality of individuals with disabilities and that their fight for disability rights is inextricably tied to the fight for racial justice and the civil rights of all people.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
an hour ago
- USA Today
Medicaid churn: How working Americans could mistakenly lose coverage under Trump tax bill
Medicaid churn: How working Americans could mistakenly lose coverage under Trump tax bill Show Caption Hide Caption President Trump gives his thoughts on Elon Musk amid clash on bill President Donald Trump responded to Elon Musk's criticism of his "big, beautiful bill" with disappointment as Musk responded on X. A centerpiece of Donald Trump's tax bill would make millions of Medicaid recipients work, volunteer or study to maintain their publicly-financed health insurance. Republicans say the work requirement is vital to protect taxpayers while motivating nondisabled Medicaid recipients to take charge of their physical and fiscal health. Dr. Mehmet Oz challenged this population to "prove that you matter." But health advocacy groups and analysts say most recipients already work in jobs that don't provide affordable health insurance or pay enough for people to afford their own insurance. They say mandating a Medicaid work requirement − combined with more frequent eligibility checks − would create an administrative nightmare that drops coverage for many who qualify for the public health insurance program for low-income and disabled residents. What is Medicaid churn? Medicaid rolls vary from month to month as people lose eligibility due to a new job, a raise or other income source that disqualifies them for coverage. A job loss or change in life circumstances could make someone newly eligible. The constant change of Medicaid rolls is what health policy experts call churn. A person who temporarily loses coverage due to a paperwork issue or mistake then must again sign up. "Churn is what happens when these eligibility systems become difficult to navigate," said Jennifer Tolbert, deputy director of the program on Medicaid and the uninsured for KFF, a health policy nonprofit. The federal government requires state Medicaid programs to check enrollees eligibility once a year. The Trump tax cut legislation would mandate states double eligibility checks to twice a year. And states would have the added duty of verifying a person's employment or exemption status. The legislation, which passed the House and awaits Senate approval, mandates Medicaid recipients who are "able-bodied" adults without children work 80 hours per month or qualify for an exemption such as being a student, caregiver or having a disability. The bill defines able-bodied as people who are not medically certified as physically or unfit for employment. The legislation also would strip coverage from undocumented immigrants who get Medicaid through state-funded programs. Health policy experts say more frequent eligibility checks and red tape will add administrative costs and cut off people who qualify but fall through the cracks due to administrative miscues. "People are going to have to document work status or exemption status multiple times a year, and at each point there's a risk that someone who is eligible could lose coverage," Tolbert said. Thousands lost coverage under Arkansas work requirement During the first Trump administration, the Centers for Medicare & Medicaid Services gave states the option of implementing a work requirement for nondisabled adults on Medicaid. Arkansas' work requirement cut more than 18,000 residents from Medicaid within the first seven months of the program. People were removed often because people were unaware of paperwork requirements to keep their coverage, research shows and analysts said. In April, a study by researchers from the Urban Institute and Loyola University Chicago found the Arkansas uninsured rate jumped 7.4 percentage points among low-income adults age 30 to 49 after the state's work requirement began. The policy's impact on employment among that age group was "negative, small and statistically insignificant," the study said. Arkansas adults who didn't have access to the internet at home were disproportionately harmed by the policy, a sign adults might've had trouble accessing the state's online portal to report work histories or exemptions, the Urban Institute said. If the work requirement for Medicaid recipients is adopted nationwide, health experts say millions of working poor Americans will inevitably lose coverage. The nonpartisan Congressional Budget Office estimated 10.9 million Americans would lose health insurance coverage through 2034 under the legislation. Most would lose coverage due to the Medicaid work requirement and the twice-a-year eligibility checks, but about 3.1 million would become uninsured from tweaks to Affordable Care Act enrollment, according to a KFF analysis. The ranks of the uninsured could grow larger if Congress doesn't extend the COVID-19 pandemic-era tax credits that have made ACA plans more affordable for consumers. If the tax credits expire and Congress passes the current version of the Trump tax bill, as many as 16 million Americans would lose coverage , according to CBO. "Coverage loss from work requirements should actually be very small," said Kathy Hempstead, a senior policy officer at the Robert Wood Johnson Foundation. "But we anticipate it will be very large, because people will not be able to comply with the requirements and will lose their coverage." Dr. Oz: Medicaid spending is 'crippling the system' The Trump administration's top Medicaid official has defended the House legislation as a necessary step to slow spending for the federal health program that covers nearly 80 million low-income and disabled Americans. In a June 4 interview with Fox Business, Dr. Oz challenged Medicaid recipients who would face work requirements should "prove that you matter." Oz, the Trump-appointed administrator of the Centers for Medicare & Medicaid Services, said the work requirement asks "able-bodied individuals who are able to go back to work at least try to get a job or volunteer or take care of a loved one who needs help or go back into school. Do something to show you have agency over your future." In a Fox News interview posted on the social media site X, Oz said Medicaid spending has surged 50% since 2019, a pace that is "crippling the system." However, some Republicans have pushed back on the proposed cuts. In a May opinion piece in the New York Times, Sen. Josh Hawley, R- Missouri, said "slashing health insurance for the working poor" is "morally wrong and politically suicidal." Survey: Americans worried about Medicaid cuts The public is paying attention to the proposed Medicaid cuts. Slightly more than half of adults said they're worried significant cuts in Medicaid spending would negatively affect their family's ability to obtain and afford health care, according to a KFF health tracking poll released June 6. The survey this survey of 2,539 U.S. adults was conducted online and by telephone over three weeks in May. The survey said nearly 6 in 10 adults said the Trump administration's policies would weaken Medicaid, but there is a stark divide based on party affiliation. Nine in 10 Democrats but just 2 in 10 Republicans expect the administration's policies would weaken Medicaid. Republicans also were far more likely than Democrats to say that the Trump's policies would strengthen Medicaid. Still, while the survey suggests people are tracking the news, many likely wouldn't know whether their coverage has changed until they try to get medical care. "People don't often know that they've lost coverage until they try and fill a prescription or see a doctor," Tolbert said.
Health Line
an hour ago
- Health Line
A Guide to the Centers for Medicare & Medicaid Services (CMS)
The Centers for Medicare & Medicaid Services (CMS) is a federal agency that provides health coverage to millions of people. It oversees programs like Medicare, Medicaid, and CHIP. The CMS works closely with the entire healthcare community to improve the equity, quality, and outcomes within the healthcare system. What is CMS? CMS is the federal agency that helps provide health coverage for more than 160 million people across the United States. It oversees the following health insurance programs: Medicare Medicaid Children's Health Insurance Program (CHIP) Health Insurance Marketplace CMS aims to strengthen and modernize the United States healthcare system and provide access to high quality care and improved health at lower costs. About Medicare Medicare is a federal health insurance program for people 65 years old and over. Those under 65 years old who have an eligible illness or disability may also qualify for coverage through Medicare. Medicare has four parts that offer different coverage for your healthcare needs: Part A: This is also known as hospital insurance. It covers inpatient care in facilities like hospitals and skilled nursing facilities. Part A also covers some home healthcare and hospice care. Part B: This is also known as medical insurance. It covers outpatient care and services you might receive from a doctor, specialist, or other healthcare professional. Part B also covers durable medical equipment (DME) and some home healthcare. Part C (Medicare Advantage): This is an alternative to Original Medicare (parts A and B). It offers the same coverage but is provided by Medicare-approved private insurance companies. Medicare Advantage plans also typically include prescription drug coverage (Part D) and additional benefits, such as vision, hearing, and dental. Part D: This offers prescription drug coverage. Part D plans are offered through Medicare-approved private insurance companies. If you have Original Medicare, you can purchase a stand-alone Part D plan from one of these companies. The CMS oversees and manages the Medicare program. The Social Security Administration (SSA) manages Medicare enrollment and income-related monthly adjustment amounts (IRMAA) for Part B and Part D. About Medicaid Medicaid is a health insurance program that is run by individual states according to federal requirements. It is funded by both the state and federal governments. Medicaid provides health coverage to around 71.1 million people, including: adults with lower incomes pregnant individuals children older adults people with disabilities It is possible for you to qualify for coverage from both Medicaid and Medicare at the same time. This can help reduce or eliminate your out-of-pocket costs. About Children's Health Insurance Program (CHIP) CHIP helps provide comprehensive health insurance benefits to children. Each state runs its own CHIP program, which means that the exact coverage and benefits may vary. While states can choose what benefits to offer in their CHIP program, there are certain healthcare services they must include: dental vaccines behavioral health well-baby and well-child visits About the Health Insurance Marketplace The Health Insurance Marketplace can help you find health coverage if you don't already have it through Medicare, Medicaid, or employment. It can also help you: find answers to questions about health insurance compare health insurance plans for affordability and coverage find out if you are eligible for tax credits for private insurance or health programs like Medicare and Medicaid enroll in a health insurance plan that meets your needs Summary The Centers for Medicare & Medicaid Services (CMS) is the federal agency that oversees health coverage programs like Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). It has a mission to strengthen the United States health system and provide access to high quality care and improved health at lower costs. The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Yahoo
2 hours ago
- Yahoo
Genetic Testing Market Research 2025: Genetic Discoveries Creating New Diagnostic Markets
Discover opportunities and pitfalls in the booming Genetic Testing industry, driven by advances in genetics and lower costs. Explore breakthroughs in Predictive Diagnostics, Pharmacogenomic Testing, and Direct-to-Consumer models across 14 countries and 5 regions. Get insights and forecasts to guide informed investment decisions. Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides" has been added to offering. The genetic testing industry is experiencing unprecedented growth, with its potential proving boundless as it expands across various sectors. This growth is being propelled by advancements in our understanding of the genetic basis of health and disease, coupled with decreasing costs. These factors are causing a surge in demand and development within the genetic testing market, presenting both opportunities and challenges. The industry's expansion is significantly influenced by the increasing realization that specific genetic profiles are crucial for the efficacy of novel therapies. Pharmacogenomics is establishing a foothold, underscoring the necessity for genetic testing to tailor drug therapies to individual genetic compositions. As this field grows, it fosters an increasing array of tests, boosting the volume of the traditional genetic testing market and its scope, while also introducing new complexities. The report examines these trends, providing detailed analyses across 14 countries and five regions. It highlights predictive diagnostics, pharmacogenomic testing, and the burgeoning direct-to-consumer segment, offering insights into the technology underpinning the industry. By doing so, it demystifies the complexities, presenting clear information on industry dynamics, opportunities, and challenges. With this comprehensive understanding, stakeholders can anticipate growth patterns and market forecasts over the next five years. The insights provided arm industry experts, investors, and decision-makers with the necessary knowledge to make informed investment decisions and valuations. In a rapidly evolving market, staying informed with the latest data is essential for maintaining a competitive advantage. Key Topics Covered: 1 Market Guides1.1 Genetic Testing - Strategic Situation Analysis & Company Rankings1.2 Guide for Executives, Marketing, Sales and Business Development Staff1.3 Guide for Management Consultants and Investment Advisors 2 Introduction and Market Definition 2.1 Genetic Testing Definition in This Report 2.2 The Genomics Revolution2.3 Market Definition2.4 Methodology2.5 Perspective: Healthcare and the IVD Industry2.6 Chromosomes, Genes and Epigenetics 3 Market Overview 3.1 Players in a Dynamic Market3.2 Genetic Tests - Types, Examples and Discussion3.3 Industry Structure 4 Market Trends4.1 Factors Driving Growth 4.1.1 Genetic Discoveries Creating New Diagnostic Markets4.1.2 The Aging Effect4.1.3 Pharmacogenomics Drives Further Growth4.1.4 Oncology and Liquid Biopsy Enter New Era4.1.5 Fertility Practice Growth drives market4.1.6 Direct to Consumer begins to break out 4.2 Factors Limiting Growth4.2.1 Increased Competition Lowers Price 4.2.2 Lower Costs4.2.3 Testing usage analysis curtailing growth 4.2.4 Wellness has a downside4.3 Instrumentation, Automation and Diagnostic Trends4.3.1 Traditional Automation and Centralization 4.3.2 The New Automation, Decentralization and Point of Care 4.3.3 Instruments Key to Market Share4.3.4 Bioinformatics Plays a Role 4.3.5 PCR Takes Command 4.3.6 Next Generation Sequencing Fuels a Revolution 4.3.7 NGS Impact on Pricing4.3.8 Whole Genome Sequencing, A Brave New World4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment 4.3.10 Shifting Role of Diagnostics 5 Genetic Testing Recent Developments5.1 Recent Developments5.1.1 Importance of This Section 5.1.2 How to Use This Section 5.2 Novitas Rescinds Coverage for Multiple Genetic Tests5.3 PerkinElmer (now Revvity) Becomes Dx Life Science Firm 5.4 New POC Genotyping Tests Based on Electromagnetic Detection 5.5 GenoMe Dx Launching dPCR Cancer Test 5.6 mDetect To Trial Breast Cancer Liquid Biopsy5.7 Genomics England, Aims to Sequence 100K Newborns 5.8 Juno Diagnostics NIPT With At-Home Sample Collection 5.9 Cardio Diagnostics Launches Genetic Cario Risk Test 5.10 Universal Genetic Testing in Breast Cancer Further Supported5.11 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests 5.12 MyOme Lands Investment for WGS5.13 Type 2 Diabetes GWAS Enables Risk Prediction 5.14 LetsGetChecked to Acquire Veritas Genetics 5.15 Guardant Health Plans New Comprehensive Assay 5.16 Tesis Labs Raises $20M 5.17 Sema4: Sema4 Elements 5.18 Clarified Precision Medicine Acquires Interpares Biomedicine5.19 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA 5.20 Illumina, Belgium Genetic Centers Partner on WGS-Based Dx5.21 NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology5.22 Progenity Revenues Fall on COVID-19 Effect 5.23 Natera Launches Tumor Genomic Profiling Assay5.24 23andMe To Go Public5.25 Guardant Health to Offer Tumor Tissue Sequencing 5.26 Ancestry Quits Health Offering5.27 DTC Firm MyDNA Merges With Gene by Gene 5.28 Aetna Coverage for NIPT to Include All Pregnancies5.29 Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing5.30 Tumor, Germline Testing of Cancer Patients Can Give Discordant Results 6 Profiles of Key Companies6.1 10x Genomics, Inc. 6.2 23andME Inc.6.3 Abbott Laboratories 6.4 Adaptive Biotechnologies 6.5 Admera Health, LLC6.6 Agilent/Dako6.7 Akonni Biosystems6.8 Amoy Diagnostics Co., Ltd. 6.9 LLC6.10 Anchor Dx 6.11 Arc Bio 6.12 Arrayit Corporation 6.13 ARUP Laboratories6.14 Aus Diagnostics6.15 BaseClear 6.16 Baylor Miraca Genetics Laboratories 6.17 Beckman Coulter Diagnostics 6.18 Becton, Dickinson and Company 6.19 BGI Genomics Co. Ltd 6.20 Bioarray Genetics 6.21 Biocept, Inc. 6.22 Biodesix Inc. 6.23 BioFluidica 6.24 BioGenex 6.25 Biolidics Ltd6.26 bioMerieux Diagnostics6.27 Bioneer Corporation6.28 Bio-Rad Laboratories, Inc6.29 Bio-Techne6.30 C2i Genomics 6.31 CareDx 6.32 Caris Molecular Diagnostics6.33 CellMax Life 6.34 Centogene 6.35 Cepheid (Danaher) 6.36 Circulogene 6.37 Clinical Genomics6.38 Color Genomics 6.39 Complete Genomics, Inc. - A BGI Company 6.40 CosmosID 6.41 Dante Labs.6.42 Datar Cancer Genetics Limited 6.43 Diasorin S.p.A. 6.44 Element Biosciences6.45 Element Biosciences6.46 Epic Sciences6.47 Epigenomics AG.6.48 Eurofins Scientific 6.49 Excellerate Bioscience 6.50 Fabric Genomics 6.51 Freenome 6.52 Fujirebio 6.53 Fulgent Genetics 6.54 Gene by Gene, Ltd. 6.55 Genedrive 6.56 GeneFirst Ltd.6.57 Genetron Holdings 6.58 Genomics England 6.59 Genomics Personalized Health (GPH)6.60 GenomOncology 6.61 Genzyme Corporation 6.62 Grifols 6.63 Guardant Health 6.64 Guardiome 6.65 HeiScreen 6.66 Helix 6.67 Helix OpCo6.68 Helomics6.69 Hologic 6.70 HTG Molecular Diagnostics 6.71 Human Longevity, Inc. 6.72 iCellate 6.73 Illumina 6.74 Incell Dx 6.75 Inivata 6.76 Integrated Diagnostics6.77 Invitae Corporation 6.78 Invivoscribe 6.79 Karius 6.80 Letsgetchecked 6.81 Lunglife AI Inc 6.82 Macrogen 6.83 MDNA Life SCIENCES, Inc.6.84 MDx Health 6.85 Medgenome6.86 Menarini Silicon Biosystems 6.87 Meridian Bioscience 6.88 Mesa Biotech (Thermo Fisher) 6.89 Mesa Laboratories, Inc. 6.90 Metabiomics Corp 6.91 miR Scientific 6.92 MNG Labs 6.93 NantHealth, Inc. 6.94 Natera 6.95 Nebula Genomics6.96 NeoGenomics 6.97 New England Biolabs, Inc. 6.98 NGeneBio6.99 Novogene Bioinformatics Technology Co., Ltd.6.100 Omega Bioservices 6.101 Oncocyte6.102 OncoDNA 6.103 OpGen 6.104 ORIG3N, Inc. 6.105 Origene Technologies 6.106 Oxford Nanopore Technologies 6.107 Pacific Biosciences 6.108 Panagene 6.109 PathoQuest S.A. 6.110 Perkin Elmer (now Revvity) 6.111 Personal Genome Diagnostics6.112 Personalis.6.113 Precipio 6.114 PrecisionMed6.115 Promega 6.116 Protagen Diagnostics 6.117 Qiagen 6.118 QuantuMDx 6.119 Roche Molecular Diagnostics 6.120 Roswell Biotechnologies 6.121 Seegene6.122 Sema4 Holdings6.123 6.124 Siemens Healthineers 6.125 simfo GmbH 6.126 Singlera Genomics Inc.6.127 Singular Genomics 6.128 SkylineDx 6.129 Standard BioTools 6.130 Sure Genomics, Inc. 6.131 Sysmex 6.132 Sysmex Inostics6.133 Tempus Labs, Inc. 6.134 Thermo Fisher Scientific Inc. 6.135 Ultima Genomics 6.136 Ultima Genomics 6.137 Variantyx 6.138 Vela Diagnostics 6.139 Volition 6.140 Vyant Bio 6.141 Zymo Research Corp 7 Global Market Size7.1 Global Market by Country7.2 Global Market by Application7.3 Global Market by Technology7.4 Global Market by Product7.5 Global Market by User 8 Market Sizes by Application8.1 Newborn Testing Market8.2 NIPT Market8.3 Predictive Testing Market8.4 Oncology Testing Market8.5 DTC Testing Market8.6 Other Testing Market 9 Global Genetic Testing Market by Technology9.1 PCR Testing Market9.2 NGS Market9.3 Cytogenetic Testing Market9.4 Other Testing Market 10 Global Genetic Testing Market by Product10.1 Instruments Market10.2 Reagents and Kits Market10.3 Software Market10.4 Services Market 11 Global Genetic Testing Market by User11.1 Academic Market11.2 Clinical Market11.3 Pharmaceutical Market11.4 Industrial and Other Market 12 The Future of Genetic Testing 13 Appendices13.1 United States Medicare System: Laboratory Fees Schedule13.2 The Most Used IVD Assays 13.3 The Highest Grossing Assays For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
